Daffodils & Cancer Research – what’s the connection?
The daffodil is a symbol of strength, of resilience, of courage and life. It survives our harsh Canadian winters to…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…
Centralized Ethics Review for Oncology Trials in Canada – An interview with Janet Manzo, Executive Director, Ontario Cancer Research Ethics Board
In this interview Janet Manzo, Executive Director of the Ontario Cancer Research Ethics Board, discusses the development of a province-wide…
Proven Approach to Site Selection is Attracting More Cutting-Edge Oncology Trials to Canada
12 Early-Phase Oncology Programs Started-Up in Canada Over Last 18-Months
Scimega Oncology, (www.scimega.com) the company behind the revolutionary Reverse Feasibility Program, announced it has been awarded
Impact of Clinical Trials on Cancer Patient Outcomes
Those of us who work in clinical operations and oncology drug development can sometimes get caught up in the operations or science and lose sight of the impact our work can have on the lives of people battling cancer. I’d like to share one man’s story to illustrate
Leveraging Canada For Quicker Oncology Site Start-Up
A biotech sponsor in the United States had targeted July 2015 for completion of enrollment for a Phase I dose-finding HER2+BrCa study.
How to Start-Up 9 Oncology Sites in 9 weeks
Over the last decade, increased competition for finite patient populations in the U.S. have led many drug developers to expand…
Top 5 Questions asked by Directors of Clinical Operations
I sat down recently with three of our Oncology Leads and asked them what questions they hear most often from…
Reverse Feasibility in Action – Transcript of interview with Dr. Quincy Chu
In this interview, Dr. Quincy Chu, Medical Oncologist at the Cross Cancer Institute in Edmonton Alberta, discusses the ways in…
Value of Canadian oncology centers for early phase trials – Transcript of interview with Dr. Stephen Welch
Given the increased focus on speed of activation for oncology studies, sponsors are under pressure to select top-performing investigative sites…